BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 20, 2026
Home » Blogs » BioWorld MedTech Perspectives » Walking the med-tech Red Carpet

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology / Biomaterials

Walking the med-tech Red Carpet

April 28, 2011
By Amanda Pedersen

A story about DSM Biomedical (Berkeley, California) that appeared in Thursday’s issue of Medical Device Daily drew a comparison between companies like DSM and the film industry’s production crew that works behind the scenes adding invaluable elements to help make the movie a success but are much less recognized and appreciated than the starring cast members.

So just for fun let’s imagine what it would be like if the med-tech industry had its own televised version of the Academy Awards. Instead of an Oscar, the coveted trophy would resemble a big gold stent. Before the show CEOs from big players like Medtronic (Minneapolis), Boston Scientific (Natick, Massachusetts), and Johnson & Johnson (New Brunswick, New Jersey) would strut down the Red Carpet in designer suits while cameras flash and reporters shout ruthless questions like “Hey, Bill Hawkins, who are you wearing?). Med-tech analysts like Wells Fargo’s Larry Biegelsen and Leerank Swann’s Rick Wise would emcee the event, providing commentary and announcing who the “golden stent” award goes to.

But there are some companies in this industry that deserve a lot of credit for their contributions to medical innovation. DSM (as well as any other company working in this space – forgive me for not listing them all) is a great example because it provides valuable biomaterials and coatings for a variety of important implants and devices. Of course we wouldn’t want to forget the venture capital community because without VCs many of the most game-changing technologies would never get to the market. Other behind-the-scenes firms that should merit a category at our med-tech awards show are GPOs and OEMs.

I know I’m probably forgetting a bunch of other key behind-the-scenes players but you get the jist. They’re out there and without them our industry would not operate the same as it does today. It would be like trying to make a movie without a camera crew.

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing